Manages hypertension. ANDA 74007, held by Ani Pharms. Acebutolol Hydrochloride.
As of Nov 16, 2026, ANDA 74007 (Acebutolol Hydrochloride), held by Ani Pharms, was first approved by FDA on Oct 18, 1995, with 8 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Hypertension Acebutolol Hydrochloride Capsules USP are indicated for the management of hypertension in adults. It may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. Ventricular Arrhythmias Acebutolol Hydrochloride Capsules USP are indicated in the management of ventricular premature beats; it reduces the total number of premature beats, as well as the number of paired and multiform ventricular ectopic beats, and R-on-T beats.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 18, 1995 | Original application | Approved | None posted |
| Acebutolol HydrochlorideEQ 200MG BASE ยท capsule;oral | Acebutolol Hydrochloride | Rx |
| Acebutolol HydrochlorideEQ 400MG BASE ยท capsule;oral | Acebutolol Hydrochloride | Rx |
| Nov 7, 2002 | Supplement 8Manufacturing | Approved | None posted |
| Jul 25, 2002 | Supplement 7Manufacturing | Approved | None posted |
| Jul 15, 2002 | Supplement 6Manufacturing | Approved | None posted |
| Sep 5, 2001 | Supplement 5Manufacturing | Approved | None posted |
| Mar 8, 2000 | Supplement 4Labeling | Approved | None posted |
| Nov 10, 1999 | Supplement 3Manufacturing | Approved | None posted |
| Aug 5, 1998 | Supplement 2Labeling | Approved | None posted |
| Jun 8, 1998 | Supplement 1Manufacturing | Approved | None posted |
| Oct 18, 1995 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters